We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

I Understand

Cenix BioScience Signs Research Service Agreement with Bayer Pharma AG

News May 06, 2014

Read Time:

Cenix BioScience GmbH (Cenix) has announced that is has signed a research service agreement with Bayer Pharma AG (Bayer).

Under the agreement, Cenix will undertake a target discovery project for an undisclosed disease indication by applying its longstanding industry-leading expertise in high throughput RNAi for genome-scale screening in advanced cell models.

Financial terms were not disclosed.

Ancient DNA Provides Insights on How Tuberculosis Shaped the Human Immune System

News

COVID-19 is only the latest infectious disease to have had an outsized impact on human life. A new study employing ancient human DNA reveals how tuberculosis has affected European populations over the past 2,000 years, specifically the impact that disease has had on the human genome.

Accurately Assessing the Transmissibility of New Virus Mutants

News

An international team including researchers from Bern has now been able to demonstrate in both the laboratory and in animal models why the D614G variant was able to gain the upper hand over the original SARS-CoV-2 virus.

Induced Pluripotent Stem Cells Reveal Causes of Disease

News

Scientists from the German Cancer Research Center and the European Molecular Biology Laboratory have studied genotype-phenotype relationships in iPSCs using data from approximately one thousand donors.

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free